[ad_1]
© REUTERS
A U.S. pharmacist has revoked its monoclonal antibody product developed by Eli Lilly and Regeneron, which has been very effective in combating previous Covid-19 complications but has been shown to be ineffective against the Omicron brand.
The Food and Drug Administration announced Monday that it is revoking the license of doctors to use the drug, which works by injecting patients with proteins that mimic the immune system.
Dr Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement: “Because the data show that the drug may not work against the Omicron brand, which is operating in the United States, the drug is not approved for use by governments. any US, regions, and regions yet. “
Regeneron’s drugs were praised for helping Donald Trump recover faster from the virus in 2020. But government agencies have banned their use because Omicron has become a major problem in the US, saying it should not disclose potential patients. as a result.
This has led to controversy with Ron DeSantis, the Republican ambassador to Florida, however, who criticized Biden officials for “playing games” and healing by barring them from giving.
[ad_2]
Source link
